What happens when genomics, KRAS, and IO converge in lung cancer?
It’s February 2nd, which means Groundhog Day in America. I was idly wondering how accurate the rodent Punxsutawney Phil was, after all, he’s got a 50:50 shot of being right or wrong. Who knew someone had analysed the predictions already and what’s more – published them?!
— CGB3 Beck (@princetongb) February 2, 2021
Meanwhile we don’t need no predictions for today’s post, where we look at the evidence gleaned from several clinical studies in lung cancer and come to some important strategic conclusions about the findings.